← Elevance Health, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net losses on financial instruments — — — — ($182.0m) ($318.0m) $550.0m $694.0m $445.0m $653.0m —
Net Income (Loss) Attributable to Parent $2.5b
$3.8b +55.59%
$3.8b -2.41%
$4.8b +28.19%
$4.6b -4.89%
$6.1b +33.51%
$6.0b -1.29%
$6.0b -0.63%
$6.0b -0.12%
$5.7b -5.32%
—
Net Income (Loss) Attributable to Noncontrolling Interest — — — — — ($9.0m) ($6.0m) $4.0m ($9.0m) ($1.0m) —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — — — — — $6.1b $6.0b $6.0b $6.0b $5.7b —
Amortization $807.8m $779.7m $1.0b $986.0m — — — — — — —
Amortization of Intangible Assets $192.3m $168.4m $358.0m $338.0m $361.0m $441.0m $767.0m $885.0m $580.0m $628.0m —
Capitalized Computer Software, Amortization — $434.6m $465.0m $450.0m $412.0m $485.0m $599.0m $685.0m $734.0m $803.0m —
Depreciation $104.0m $110.7m $124.0m $147.0m $176.0m $136.0m $123.0m $107.0m $105.0m $94.0m $1.5b
Depreciation and amortization $576.0m $601.0m $652.0m $675.0m $638.0m $668.0m $784.0m $872.0m $1.4b $1.5b $1.5b
Depreciation, Amortization and Accretion, Net — — $1.1b $1.1b $1.2b $1.3b $1.7b $1.7b $1.4b $1.5b $1.5b
Depreciation, Depletion and Amortization $104.0m $110.7m $124.0m $147.0m $1.2b $1.3b $1.7b $1.7b $1.4b $1.5b $1.5b
Deferred Income Tax Expense (Benefit) $126.9m ($1.3b) $91.0m $81.0m ($540.0m) $326.0m ($76.0m) ($602.0m) ($374.0m) ($279.0m) ($176.0m)
Deferred Other Tax Expense (Benefit) $129.1m ($1.3b) $112.0m $75.0m ($526.0m) $180.0m $4.0m ($690.0m) ($361.0m) — —
Payment, Tax Withholding, Share-based Payment Arrangement — $46.5m $81.0m $84.0m $128.0m $102.0m $93.0m $99.0m $109.0m $32.0m —
Share-based Payment Arrangement, Noncash Expense $164.6m $169.6m $226.0m $294.0m $283.0m $255.0m $264.0m $289.0m $191.0m $276.0m $244.0m
Share-based compensation $164.6m $169.6m $226.0m $294.0m $283.0m $255.0m $264.0m $289.0m $191.0m $276.0m $244.0m
Operating Lease, Impairment Loss — — — — $258.0m $136.0m $34.0m $23.0m $17.0m $7.0m —
Income (Loss) from Equity Method Investments — — — — — $562.0m $293.0m ($33.0m) $1.0m $398.0m —
Changes in operating assets and liabilities:
Receivables, net ($1.4b) ($22.2m) ($695.0m) ($1.1b) ($256.0m) ($2.1b) ($2.5b) ($1.8b) ($683.0m) ($2.5b) —
Accounts payable and other liabilities — — $97.0m ($445.0m) $2.0b $719.0m $824.0m $1.6b ($272.0m) ($720.0m) $1.7b
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims $65.5b $70.7b $68.7b $78.2b $84.5b $98.7b $112.5b $120.2b $123.6b $144.3b —
Unearned income ($173.6m) ($120.1m) ($36.0m) $115.0m $202.0m ($113.0m) ($42.0m) $290.0m ($113.0m) ($15.0m) —
Increase (Decrease) in Other Operating Assets $127.7m $629.0m $26.0m $170.0m $283.0m ($37.0m) ($120.0m) $675.0m ($824.0m) ($57.0m) —
Other assets ($127.7m) ($629.0m) ($26.0m) ($170.0m) ($283.0m) $37.0m $120.0m ($675.0m) $824.0m $57.0m —
Net Cash Provided by (Used in) Operating Activities $3.2b
$4.2b +30.59%
$3.8b -8.55%
$6.1b +58.37%
$10.7b +76.34%
$8.4b -21.74%
$8.4b +0.42%
$8.1b -4.02%
$5.8b -27.95%
$4.3b -26.14%
$7.5b +73.99%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment ($4.5m) ($13.0m) ($8.0m) ($3.0m) $198.0m $73.0m $7.0m $446.0m $103.0m $108.0m ($635.0m)
Payments to Acquire Property, Plant, and Equipment $583.6m $799.5m $1.2b $1.1b $1.0b $1.1b $1.2b $1.3b $1.3b $1.1b ($1.2b)
Maturities, calls and redemptions from investments $1.4b $1.8b $1.9b $2.4b $4.7b $4.3b $10.6b $2.9b $2.0b $1.8b —
Payments to Acquire Investments — — — — $19.5b $18.7b $24.9b $16.2b $18.0b $15.0b ($14.8b)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $1.4b $1.8b $1.9b $2.4b $4.7b $4.3b $10.6b $2.9b $2.0b $1.8b —
Proceeds from sale of investments — — $9.7b $18.6b $11.3b $10.3b $12.0b $10.6b $16.5b $13.3b $13.7b
Purchases of investments — — ($9.7b) ($23.0b) ($19.5b) ($18.7b) ($24.9b) ($16.2b) ($18.0b) ($15.0b) —
Restricted Cash and Investments, Current $157.0m $91.2m $222.0m $215.0m $170.0m $173.0m $258.0m $294.0m $409.0m $348.0m —
Payments to Acquire Businesses, Net of Cash Acquired $0 $2.1b $1.8b $0 $2.0b $3.5b $649.0m $1.6b $4.8b ($88.0m) ($4.8b)
Payments for (Proceeds from) Other Investing Activities $3.0m ($11.9m) $71.0m $50.0m $45.0m $63.0m $120.0m $102.0m $124.0m $0 —
Net Cash Provided by (Used in) Investing Activities ($513.9m) ($5.1b) ($1.3b) ($2.8b) ($7.3b) ($9.6b) ($4.6b) ($5.6b) ($5.2b) ($1.3b) ($2.2b)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt $0 ($282.4m) ($11.0m) ($2.0m) ($36.0m) ($21.0m) $0 $0 — — —
Proceeds from Issuance of Long-term Debt $0 $5.5b $835.0m $2.5b $2.5b $3.5b $3.1b $2.6b $7.7b $3.0b $5.1b
Proceeds from long-term borrowings, net issuance costs $0 $5.5b $835.0m $2.5b $2.5b $3.5b $3.1b $2.6b $7.7b $3.0b —
Proceeds from short-term borrowings $2.4b $5.8b $9.1b $7.6b $970.0m $1.3b $1.4b $225.0m $275.0m $1.5b —
Repayments of Long-term Debt $0 $2.8b $1.7b $1.1b $1.9b $1.1b $1.9b $1.9b $1.6b $2.1b ($1.6b)
Repayments of long-term borrowings $0 ($2.8b) ($1.7b) ($1.1b) ($1.9b) ($1.1b) ($1.9b) ($1.9b) ($1.6b) ($2.1b) —
Repayments of short-term borrowings ($2.5b) ($5.0b) ($9.2b) ($8.0b) ($1.7b) ($1.1b) ($1.4b) ($265.0m) ($135.0m) ($1.7b) —
Payments for Repurchase of Common Stock $0 $2.0b $1.7b $1.7b $2.7b $1.9b $2.3b $2.7b $2.9b $2.6b —
Proceeds from Issuance of Common Stock $119.4m $225.3m $1.2b $0 $0 $203.0m $182.0m $152.0m $221.0m $79.0m —
Proceeds from issuance of common stock under employee stock plans $119.4m $225.3m $173.0m $187.0m $176.0m $203.0m $182.0m $152.0m $221.0m $79.0m —
Repurchase and retirement of common stock $0 ($2.0b) ($1.7b) ($1.7b) ($2.7b) ($1.9b) ($2.3b) ($2.7b) ($2.9b) ($2.6b) —
Taxes paid through withholding of common stock under employee stock plans ($65.7m) ($46.5m) ($81.0m) ($84.0m) ($128.0m) ($102.0m) ($93.0m) ($99.0m) ($109.0m) ($32.0m) —
Cash dividends ($684) ($705) ($776) ($818) ($954) ($1k) ($1k) ($1k) ($2k) ($2k) ($1.5b)
Dividends paid $684.0m $704.9m $776.0m $818.0m $954.0m $1.1b $1.2b $1.4b $1.5b $1.5b ($1.5b)
Proceeds from (Payments for) Other Financing Activities — — — — $488.0m ($349.0m) $41.0m $7.0m $2.0m $22.0m —
Net Cash Provided by (Used in) Financing Activities ($732.9m)
$426.9m +158.25%
($2.2b) -624.95%
($2.3b) -1.12%
($2.6b) -13.28%
$423.0m +116.48%
($1.3b) -411.58%
($3.3b) -154.10%
$1.2b +135.62%
($1.7b) -245.68%
($3.5b) -103.11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4.1m $4.3m ($2.0m) $0 $804.0m ($861.0m) $2.5b ($861.0m) $1.8b $1.2b $10.3b
Cash and cash equivalents at beginning of year $2.1b $4.1b $3.6b $3.9b $4.9b $5.7b $7.4b $6.5b $8.3b $9.5b $8.6b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — — — $7.4b $6.5b $8.3b $9.5b $10.3b
Changes in securities lending collateral $222.0m $624.5m ($149.0m) $254.0m ($849.0m) ($956.0m) ($301.0m) $78.0m $73.0m ($385.0m) —
Changes in securities lending payable ($222.0m) ($624.5m) $150.0m ($254.0m) $849.0m $956.0m $302.0m ($77.0m) ($75.0m) $386.0m —
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.1m $4.3m ($2.0m) $0 $7.0m ($10.0m) ($14.0m) ($1.0m) ($6.0m) ($5.0m) ($19.0m)
Effect of foreign exchange rates on cash and cash equivalents $4.1m $4.3m ($2.0m) $0 $7.0m ($10.0m) ($14.0m) ($1.0m) ($6.0m) ($5.0m) —
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Change in cash and cash equivalents $2.0b ($466.4m) $325.0m $1.0b $804.0m ($861.0m) $2.5b ($861.0m) $1.8b $1.2b —
Changes in bank overdrafts $513.8m $71.0m ($210.0m) ($169.0m) $486.0m ($376.0m) $933.0m $114.0m ($638.0m) $1.3b —
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — — — ($9.0m) ($29.0m) ($26.0m) ($28.0m) ($7.0m) — — —
Derivative, Gain (Loss) on Derivative, Net ($207.5m) ($48.3m) $23.0m ($17.0m) ($2.0m) $7.0m $80.0m $8.0m $10.0m ($2.0m) —
Equity Securities, FV-NI, Gain (Loss) — — — — — ($71.0m) — — — — —
Equity Securities, FV-NI, Realized Gain (Loss) — — — — — ($73.0m) — — — — —
Equity Securities, FV-NI, Unrealized Gain (Loss) — — — — — $2.0m — — — — —
Equity in net (earnings) losses of other invested assets — — — ($93.0m) ($51.0m) ($562.0m) ($293.0m) $33.0m ($1.0m) ($398.0m) —
Gain (Loss) on Disposition of Business — — — — — — — — $201.0m $0 —
Gain on sale of business — — — — — — $0 $0 ($201.0m) $0 —
General and Administrative Expense $11.2b $11.3b — — — — — — — — —
Goodwill $17.6b $19.2b $20.5b $20.5b $21.7b $24.2b $24.4b $25.3b $28.3b $28.3b $145.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $2.5b — — — — — — — — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $0 — — — — — — — — — —
Income Tax Expense (Benefit) $2.1b $121.0m $1.3b $1.2b $1.7b $1.8b $1.8b $1.7b $1.9b $1.0b —
Income taxes $178.8m ($193.9m) $323.0m ($325.0m) $72.0m $140.0m ($338.0m) ($103.0m) $404.0m ($297.0m) —
Insurance Services Revenue $84.2b $89.1b $91.3b $103.1b $120.8b $136.9b $155.7b — — — —
Interest Expense Nonoperating — — — — — — — — $1.2b $1.4b —
Less cash and cash equivalents included in assets held for sale at end of year — — — — — — $0 $0 ($66.0m) $0 —
Other invested assets ($19.4m) ($35.5m) ($1.0m) ($48.0m) ($32.0m) ($70.0m) $11.0m ($79.0m) ($78.0m) $0 —
Other, net ($3.0m) $11.9m ($71.0m) ($50.0m) $488.0m ($349.0m) $41.0m $7.0m $2.0m $22.0m —
Policy liabilities $321.7m $731.6m ($1.1b) $1.8b $3.5b $2.6b $2.3b $147.0m ($1.8b) $228.0m —
Proceeds from Stock Options Exercised $119.4m $225.3m $173.0m $187.0m $176.0m $203.0m $182.0m $152.0m $154.0m $51.0m —
Proceeds from sales of subsidiaries, net of cash sold — — — — — — $0 $0 $363.0m $0 —
Purchases of subsidiaries, net of cash acquired $0 ($2.1b) ($1.8b) $0 ($2.0b) ($3.5b) ($649.0m) ($1.6b) ($4.8b) $88.0m —
Realized Investment Gains (Losses) $220.1m $200.3m ($203.0m) $131.0m $184.0m — — — — — —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.